These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 32962495)

  • 21. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis and COVID-19.
    Mares J; Hartung HP
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):217-225. PubMed ID: 32686774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis.
    Jesenak M; Brndiarova M; Urbancikova I; Rennerova Z; Vojtkova J; Bobcakova A; Ostro R; Banovcin P
    Front Cell Infect Microbiol; 2020; 10():364. PubMed ID: 32695683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.
    Liu X; Cao W; Li T
    Front Immunol; 2020; 11():1660. PubMed ID: 32760407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
    Leisman DE; Mastroianni F; Fisler G; Shah S; Hasan Z; Narasimhan M; Taylor MD; Deutschman CS
    Crit Care Explor; 2020 Oct; 2(10):e0230. PubMed ID: 33063034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom.
    Liu Z; Magal P; Webb G
    J Theor Biol; 2021 Jan; 509():110501. PubMed ID: 32980371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible effects of mixed prevention strategy for COVID-19 epidemic: massive testing, quarantine and social distancing.
    Kuniya T; Inaba H
    AIMS Public Health; 2020; 7(3):490-503. PubMed ID: 32968673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology.
    Kole A; Bag AK; Pal AJ; De D
    BMC Bioinformatics; 2024 Feb; 25(1):74. PubMed ID: 38365632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential new COVID-19 treatments via RWD-driven drug repurposing.
    Liao Y
    Sci Rep; 2023 Sep; 13(1):14586. PubMed ID: 37666866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study.
    El-Derany MO; Hanna DMF; Youshia J; Elmowafy E; Farag MA; Azab SS
    Pharmacol Rep; 2023 Oct; 75(5):1045-1065. PubMed ID: 37587394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nanoplatform-based aptasensor to electrochemically detect epinephrine produced by living cells.
    Fredj Z; Wang P; Ullah F; Sawan M
    Mikrochim Acta; 2023 Aug; 190(9):343. PubMed ID: 37540351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced Nanomaterials-Based Electrochemical Biosensors for Catecholamines Detection: Challenges and Trends.
    Fredj Z; Sawan M
    Biosensors (Basel); 2023 Jan; 13(2):. PubMed ID: 36831978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference.
    Wang J; Liu J; Luo M; Cui H; Zhang W; Zhao K; Dai H; Song F; Chen K; Yu Y; Zhou D; Li MJ; Yang H
    iScience; 2022 Nov; 25(11):105348. PubMed ID: 36267550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating heterogeneous data to facilitate COVID-19 drug repurposing.
    Prieto Santamaría L; Díaz Uzquiano M; Ugarte Carro E; Ortiz-Roldán N; Pérez Gallardo Y; Rodríguez-González A
    Drug Discov Today; 2022 Feb; 27(2):558-566. PubMed ID: 34666181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal variations in COVID-19: an epidemiological discussion with a practical application.
    Derakhshan M; Ansarian HR; Ghomshei M
    J Int Med Res; 2021 Aug; 49(8):3000605211033208. PubMed ID: 34369194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19.
    Sharma T; Abohashrh M; Baig MH; Dong JJ; Alam MM; Ahmad I; Irfan S
    Saudi J Biol Sci; 2021 May; 28(5):3152-3159. PubMed ID: 33649700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.